Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 1, 2020 at 10:34 AM EDT

Why Solid Bio’s Future Just Got a Lot Brighter

Solid Biosciences shares more than doubled on Thursday after the company announced a key update from the FDA.

Lee Jackson | Oct 1, 2020 at 7:48 AM EDT

Health Care REITs Offer Safety and Large Dividends as Pandemic Changes Landscape

Compared to the office and retail real estate investment trusts, which have been hit hard during the pandemic, the medical…

Chris Lange | Sep 30, 2020 at 9:22 AM EDT

2 Big Positive Developments in the COVID-19 Vaccine Race

Moderna and Regeneron Pharmaceuticals each announced positive news late on Tuesday about their respective COVID-19 vaccine trials.

Lee Jackson | Sep 30, 2020 at 7:42 AM EDT

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that…

Chris Lange | Sep 29, 2020 at 11:40 AM EDT

Why Aptorum Stock Absolutely Took Off on Tuesday

Aptorum shares absolutely exploded on Tuesday after the company announced that it would be launching a subsidiary focused on novel…

Douglas A. McIntyre | Sep 29, 2020 at 6:16 AM EDT

This Is the State Where Alzheimer’s Is Surging

Almost 6 million Americans 65 and older are living with Alzheimer’s disease. In one state, the number is expected to…

Chris Lange | Sep 28, 2020 at 3:08 PM EDT

Genfit and Lab Corp Partner Up For NASH Liver Test

Genfit SA (NASDAQ: GNFT) shot up on Monday after the company announced an agreement with Lab Corporation of America Holdings…

Chris Lange | Sep 28, 2020 at 11:10 AM EDT

Eiger BioPharmaceuticals COVID-19 Study Fails to Live Up to Expectations

Eiger BioPharmaceuticals has announced disappointing results from a study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.

Chris Lange | Sep 28, 2020 at 10:14 AM EDT

Should Aquestive Therapeutics Be Worried About This FDA Response?

Aquestive Therapeutics said that it had received a negative response from the FDA concerning its treatment for the management of…

Chris Lange | Sep 28, 2020 at 9:05 AM EDT

Is the FDA’s Hold on Inovio’s COVID-19 Vaccine Study Too Much?

Things aren’t looking up for Inovio Pharmaceuticals, after the FDA notified the company that it was placing a partial hold…

Lee Jackson | Sep 28, 2020 at 7:19 AM EDT

5 Jefferies High-Conviction Health Care Stocks May Be Huge Q4 Winners

These five high-conviction health care stock picks from the analysts at Jefferies all make sense for investors looking to gain…

Douglas A. McIntyre | Sep 26, 2020 at 8:37 AM EDT

This Is the Country COVID-19 Has Hit the Hardest

By a count of confirmed COVID-19 cases relative to the total size of the population, Peru is the nation hurt…

Chris Lange | Sep 25, 2020 at 9:54 AM EDT

Biotech Short Sellers Hike Their Bets

The September 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 24, 2020 at 3:36 PM EDT

Why Amgen Is Called to Outperform Large-Cap Biotechs

Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20%…

Jon C. Ogg | Sep 24, 2020 at 11:32 AM EDT

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

Some small-cap companies will screen as having deep value, but many value stocks are deemed to be "cheap" because they…

1 … 39 40 41 42 43 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Solid Bio’s Future Just Got a Lot Brighter

Health Care REITs Offer Safety and Large Dividends as Pandemic Changes Landscape

2 Big Positive Developments in the COVID-19 Vaccine Race

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

Why Aptorum Stock Absolutely Took Off on Tuesday

This Is the State Where Alzheimer’s Is Surging

Genfit and Lab Corp Partner Up For NASH Liver Test

Eiger BioPharmaceuticals COVID-19 Study Fails to Live Up to Expectations

Should Aquestive Therapeutics Be Worried About This FDA Response?

Is the FDA’s Hold on Inovio’s COVID-19 Vaccine Study Too Much?

5 Jefferies High-Conviction Health Care Stocks May Be Huge Q4 Winners

This Is the Country COVID-19 Has Hit the Hardest

Biotech Short Sellers Hike Their Bets

Why Amgen Is Called to Outperform Large-Cap Biotechs

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Health and Healthcare Articles

All Health and Healthcare Articles

Why Solid Bio’s Future Just Got a Lot Brighter

Health Care REITs Offer Safety and Large Dividends as Pandemic Changes Landscape

2 Big Positive Developments in the COVID-19 Vaccine Race

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

Why Aptorum Stock Absolutely Took Off on Tuesday

This Is the State Where Alzheimer’s Is Surging

Genfit and Lab Corp Partner Up For NASH Liver Test

Eiger BioPharmaceuticals COVID-19 Study Fails to Live Up to Expectations

Should Aquestive Therapeutics Be Worried About This FDA Response?

Is the FDA’s Hold on Inovio’s COVID-19 Vaccine Study Too Much?

5 Jefferies High-Conviction Health Care Stocks May Be Huge Q4 Winners

This Is the Country COVID-19 Has Hit the Hardest

Biotech Short Sellers Hike Their Bets

Why Amgen Is Called to Outperform Large-Cap Biotechs

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts